Stocks from New York to Tokyo to Frankfurt rallied Thursday, even as President Trump slapped new tariffs on imports from India and South Korea, escalating his ...

Sanofi’s SAR446523, a GPRC5D monoclonal antibody, earns orphan drug designation in the US for multiple myeloma Designation granted for IgG1-based GPRC5D monoclonal antibody for the potential treatment ...

Big tech earnings have inspired a substantial rise in Nasdaq futures in overnight trading after the Federal Reserve, led by ...

In 2025, sales are anticipated to grow by a high single-digit percentage at CER (previously mid-to-high single-digit). Sanofi confirms the expectation of a strong business EPS rebound with growth at a ...

Net profit more than tripled to 3.94 billion euros, flattered by a gain from Sanofi's sale of a majority stake in its Opella consumer-healthcare arm. Business EPS came in at 1.59 euros, up 8.3% ...

Owing to Briumvi's solid launch, TG's balance sheet is in excellent condition. Despite new competition, Briumvi's five-year ...

Swedish biotech Oncopeptides (Nasdaq Stockholm: ONCO) has entered into a partnership with Spanish pharmaceutical broker SD ...

USA-based Madrigal Pharmaceuticals today announced that it has entered into an exclusive global license agreement with CSPC ...

Swiss pharma company Idorsia today released encouraging first half 2025 financial results, sending its shares up 8.5% to 2.94 ...

US biopharma Viridian Therapeutics has entered into an exclusive collaboration and license agreement with Japanese firm Kissei Pharmaceutical (TYO: 4547) to develop and commercialize veligrotug and ...

Shares of DURECT Corporation shot up 240% to $1.88 by close of trading Tuesday, after Canada’s Bausch Health agreed to ...